{"id":"W2023398941","doi":"10.1016/j.ygyno.2007.08.084","title":"Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Carboplatin; Medicine; Ifosfamide; Paclitaxel; Urology; Chemotherapy; Endometrial cancer; Uterine cancer; Oncology; Internal medicine; Cancer; Gynecology; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005856781,0.0002324163,0.0008155482,0.00004640968,0.0005174289,0.00007862505,0.0002659081,0.000244489,0.003882212],"category_scores_gemma":[0.001278342,0.000185304,0.0001972472,0.0004754075,0.0002552306,0.00006123706,0.0001310336,0.0002435779,0.00001557729],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001226798,"about_ca_system_score_gemma":0.0006166892,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.009203847,"about_ca_topic_score_gemma":0.1910022,"domain_scores_codex":[0.9974499,0.0001161467,0.0007078247,0.0006216894,0.0002507461,0.0008537108],"domain_scores_gemma":[0.9975555,0.00131716,0.0002969553,0.0003458881,0.0001921889,0.0002922933],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.004600382,0.0009710409,0.01273717,0.0001689652,0.0001880012,0.001554356,0.0009507801,0.000009482982,0.002333804,0.0000347099,0.005350242,0.971101],"study_design_scores_gemma":[0.02521711,0.01793602,0.5680376,0.0002032028,0.0002993277,0.0004817639,0.002518021,0.00009360816,0.001181239,0.0005600369,0.3828798,0.0005922727],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880831,0.001797199,0.0002089831,0.001170288,0.002957703,0.002767814,0.0001355522,0.0001064438,0.002772897],"genre_scores_gemma":[0.9834353,0.0008880714,0.002686939,0.00201236,0.000486056,0.002498185,0.00005416714,0.00003241049,0.007906525],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9705088,"threshold_uncertainty_score":0.997394,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04979267677869392,"score_gpt":0.3714260174683374,"score_spread":0.3216333406896435,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}